Xanthoangelol

Xanthoangelol

SCHEMBL5519356

CC(C)=CCC/C(C)=C/Cc1c(O)ccc(C(=O)C=Cc2ccc(O)cc2)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 1.00
LMNA P02545 2/20 1.00
MAPT P10636 2/20 1.00
MAOB P27338 2/20 1.00
KMT2A Q03164 2/20 1.00
ALDH1A1 P00352 1/20 1.00
GAA P10253 1/20 1.00
PTPN1 P18031 2/20 0.81
DHODH Q02127 1/20 0.81
MGAM O43451 1/20 0.72
CASP3 P42574 1/20 0.70
SENP8 Q96LD8 1/20 0.70
SENP7 Q9BQF6 1/20 0.70
SENP6 Q9GZR1 1/20 0.70
PTGS1 P23219 2/20 0.69
PTGS2 P35354 2/20 0.69
CYP19A1 P11511 2/20 0.60
TYR P14679 2/20 0.60
PPARG P37231 2/20 0.60
PPARA Q07869 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xanthoangelol SCHEMBL454823 1.00 MEN1 (1.00) MEN1LMNAMAPTMAOBKMT2A
Xanthoangelol SCHEMBL5519362 1.00 MEN1 (1.00) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL5515022 0.99 MEN1 (0.98) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL14523853 0.99 MEN1 (0.98) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL5515052 0.92 MAOB (0.84) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL5515048 0.92 MAOB (0.84) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL5515045 0.92 MAOB (0.84) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL14523856 0.91 MEN1 (0.84) MEN1LMNAMAPTMAOBKMT2A
SCHEMBL21716621 0.90 MAOB (0.82) MEN1LMNAMAPTMAOBKMT2A
Isobavachalcone SCHEMBL600137 0.90 PTPN1 (1.00) MEN1LMNAMAPTMAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4202130-A None JP disclosed
JP-2164822-A None JP disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP disclosed
JP-H04202130-A ANTIBACTERIAL AGENT TAISHO PHARMACEUT CO LTD 1992-07-22 JP disclosed
JP-H02164822-A (H++K+)-ADENOSINE TRIPHOSPHATASE INHIBITOR TAISHO PHARMACEUT CO LTD 1990-06-25 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070092551-A1 Therapeutic agent FABP4, GPR119, IAPP MEN1 2467/4885LMNA 2982/4885MAPT 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.